Medications for Opioid Use Disorders (MOUD) are recommended for individuals with an opioid use disorder, including pregnant women. While facilitating pathways to recovery for the person with an opioid use disorder (OUD) is appropriate, it is important to consider and address the severe effects OUD has on family relationships and functioning. Children are especially vulnerable and are at an increased risk of trauma, academic challenges, or child neglect, which can disrupt healthy development.
This interactive webinar will define opioid use disorder (OUD), review adverse effects of opioid use on family dynamics, and review behavioral and developmental concerns for children, including neonatal abstinence syndrome (NAS). The content will also discuss medications recommended to treat OUD and inform on approaches to support healthy recovery for children and family wellness.

Trainer: Diana Padilla, MCPC, CARC, CASAC-T, is a Research Project Manager at New York State Psychiatric Institute, Columbia University Medical Center. She is a senior staff trainer for the Northeast & Caribbean Addiction Transfer Technology Center Network (NeC-ATTC), and a member of the ASAP-NYCB Trainer Registry. As a cultural agent, Ms. Padilla promotes an equity lens in trainings for engaging diverse communities in need, aligning with evidence and strength-based strategies within behavioral health, addiction, prevention, and recovery supports fields and professional capacities.

Credits: This training meets the requirements for two renewal hours (CASAC, CPP, CPS) and two initial hours (CPP, CPS) through New York State’s Office of Addiction Services and Supports (NYS OASAS). As an IC & RC member board, OASAS accredited courses are granted reciprocal approval by the New Jersey Division of Consumer Affairs, Alcohol and Drug Counselor Committee. Many other states offer reciprocity - please check with your accrediting agency.